1. Home
  2. Marc Arbyn
  3. Marc Arbyn

Primary tabs

Search
Limit to
Export 219 results:
Filters: Author is M. Arbyn
2013
Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia., Poljak, Mario, Rogovskaya Svetlana I., Kesić Vesna, Bray Freddie, Berkhof Johannes, Seme Katja, Brotons Maria, Castellsagué Xavier, Syrjänen Stina, Arbyn M., et al. , Vaccine, 2013 Dec 31, Volume 31 Suppl 7, p.H80-2, (2013)
Transmission of carcinogenic human papillomavirus types from mother to child: a meta-analysis of published studies, Merckx, M., Wildero-Van Wouwe Liesbeth, Arbyn M., Meys J., Weyers S., Temmerman M., and D. Broeck Vanden , Eur.J.Cancer Prev., 1/5/2013, Volume 22, Issue 3, Number 285, p.277 - 285, (2013)
Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types., Verdoodt, Freija, Szarewski Anne, Halfon Philippe, Cuschieri Kate, and Arbyn M. , Cancer Cytopathol, 2013 Dec, Volume 121, Issue 12, Number 687, p.675-87, (2013)
Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions, Schmitt, M., Depuydt C., Benoy I., Bogers J., Antoine Jérôme, and Arbyn M. , Cancer Epidemiol.Biomarkers Prev., 12/2/2013, Volume 22, Number 414, p.406 - 414, (2013)
Which HPV tests can be used? Meta-analyses of performance of different HPV tests in primary screening., Arbyn, M. , 6 th European Congress of the European Federation for Colposcopy and Cervical Pathology, 7/9/2013, Issue European Federation for Colposcopy and Cervical Pathology, (2013)
2012
Adverse obstetrical outcomes after treatment of precancerous cervical lesions: a Belgian multicentre study., Simoens, Cindy, Goffin F, Simon P, Barlow P, Antoine Jérôme, Foidart J-M, and Arbyn M. , BJOG, 2012 Sep, Volume 119, Issue 10, p.1247-55, (2012)
Analyse des données individuelles des organismes assureurs sur les frottis de col de l'uterus, les colposcopies, les biopsies cervicales et la chirurgie du col de l'uterus (Belgique, 2002-2006), Arbyn, M., Simoens Cindy, and Fabri V. , Epi-Scoop, 0/2/2012, Volume 12, Number 4, Brussels, p.4 - 4, (2012)
Analyse van individuele sociale zekerheidsgegevens over uitstrijkjes, colposcopieën, biopsieën en chirurgische ingrepen op de baarmoederhals (België, 2002-2006), Arbyn, M., Simoens Cindy, and Fabri V. , Epi-Scoop, 0/2/2012, Volume 12, Number 4, Brussel, p.4 - 4, (2012)
Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology, Siebers, A.G., Klinkhamer P.J.J.M., Vedder J.E.M., Arbyn M., and Bulten J. , Arch.Pathol.Lab Med, 0/1/2012, Volume 136, Issue 1, Number 83, p.76 - 83, (2012)
Cervical cancer screening in the European Union: burden & screening coverage, Arbyn, M. , Symposium of the European Cancer Health Indicator Project, 26/2/2012, Issue Instituto Nazionale Tumori, (2012)
Cochrane Review: Cervical Cancer Screening in developing countries, Arbyn, M. , Fourth Helsinki Symposium on HPV Vaccination, 12/1/2012, Issue University of Helsinki, University of Tampere, Finnish Medical Society, (2012)
Cochrane Review: Safety, immunogenecity and efficacy of prophylactic HPV vaccines, Arbyn, M. , Fourth Helsinki Symposium on HPV Vaccination, 12/1/2012, Issue University of Tampere, University of Helsinki, Finnish Medical Society, (2012)
Is the colposcopically-directed punch biopsy a reliable diagnostic test in women with minor cytological lesions?, Moss, E.L, Hadden P., Douce G., Jones P.W., Arbyn M., and Redman C.W.E. , J.Low Genit.Tract.Dis., 4/6/2012, Volume 16, Issue 4, (2012)
Effect of screening on deaths from cervical cancer in Sweden, Arbyn, M., Weiderpass E., and Capocaccia R. , BMJ, 1/3/2012, Volume 344, p.e804, (2012)
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease., Arbyn, M., de Sanjosé Silvia, Saraiya Mona, Sideri Mario, Palefsky Joel, Lacey Charles, Gillison Maura, Bruni Laia, Ronco Guglielmo, Wentzensen Nicolas, et al. , Int J Cancer, 2012 Nov 01, Volume 131, Issue 9, p.1969-82, (2012)
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer., Arbyn, M., Ronco Guglielmo, Anttila Ahti, Meijer Chris J. L. M., Poljak Mario, Ogilvie Gina, Koliopoulos George, Naucler Pontus, Sankaranarayanan Rengaswamy, and Peto Julian , Vaccine, 2012 Nov 20, Volume 30 Suppl 5, p.F88-99, (2012)
Highlights of the 27th International Papillomavirus Conference and Clinical Workshop (Berlin, 17-22 September 2011) - Part 2: Applied Clinical Science, Arbyn, M., and Gissmann L. , 27th International Papillomavirus Conference and Clinical Workshop, 0/1/2012, Volume 7, Issue Schneider,A., Gissman,L., Kaufmann,A., Number 24, p.19 - 24, (2012)
Highlights of the 27th International Papillomavirus Conference and Clinical Workshop (Berlin, 17-22 September 2011) - Part 2: Applied Clinical Science, Arbyn, M., Schneider A., Gissmann L., and Kaufmann A.M. , Future Virol., 0/0/2012, Volume 7, Issue 1, Number 24, p.19 - 24, (2012)
Highlights of the 27th International Papillomavirus Conference and Clinical Workshop (Berlin, 17-22 September 2011) - Part 3: Epidemiology and Public Health, Arbyn, M., and Gissmann L. , 27th International Papillomavirus Conference and Clinical Workshop, 0/2/2012, Volume 7, Issue Schneider,A., Gissman,L., Kaufmann,A., Number 133, p.127 - 133, (2012)
Hoofdstuk 15: Optimale afname van cellen van de baarmoederhals voor cervixscreening, Buntinx, F.J., van der Putten H.W.H.M., and Arbyn M. , Gynaecologie, 0/0/2012, Number 206, Houten (the Netherlands), p.277, (2012)
Impact of genetic notification on smoking cessation: Pooled analysis, de Viron, S., Van der Heyden Johan, Ambrosio E., Arbyn M., Brand A., and Van Oyen Herman , 0/0/2012, Number 47, Brussels, p.45 - 47, (2012)
Impact of genetic notification on smoking cessation: systematic review and pooled-analysis., de Viron, Sylviane, Van der Heyden Johan, Ambrosino Elena, Arbyn M., Brand Angela, and Van Oyen Herman , PLoS One, 2012, Volume 7, Issue 7, p.e40230, (2012)
Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis, de Bekker-Grob, E.W., de Kok I.M., Bulten J., van Rosmalen J., Vedder J.E.M., Arbyn M., Klinkhamer P.J.J.M., Siebers A.G., and van Ballegooijen M. , Cancer Causes Control, 17/6/2012, Volume 23, Issue 8, Number 1331, p.1323 - 1331, (2012)
p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis., Roelens, Jolien, Reuschenbach Miriam, Doeberitz Magnus von Knebel, Wentzensen Nicolas, Bergeron Christine, and Arbyn M. , Cancer Cytopathol, 2012 Oct 25, Volume 120, Issue 5, p.294-307, (2012)
Prevention of human papillomavirus-related malignancies of the female genital tract, Koliopoulos, G., and Arbyn M. , Infect.Dis.Obstet.Gynecol., 5/4/2012, Volume 2011, (2012)

QR code

QR code for this page URL